FORA Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Buy
38,470
+22,545
+142% +$12.6M 1.39% 8
2026
Q1
$8.95M Buy
+15,925
New +$10.2M 0.66% 46
2025
Q3
Sell
-2,626
Closed -$1.41M 580
2025
Q2
$1.41M Buy
+2,626
New +$1.26M 0.16% 171
2024
Q4
Sell
-4,129
Closed -$2.09M 482
2024
Q3
$2.09M Buy
4,129
+2,877
+230% +$1.4M 0.25% 122
2024
Q2
$610K Buy
+1,252
New +$629K 0.07% 274
2023
Q4
Sell
-9,404
Closed -$4.11M 522
2023
Q3
$4.11M Buy
9,404
+6,569
+232% +$3.28M 0.36% 83
2023
Q2
$1.42M Buy
+2,835
New +$1.36M 0.2% 132
2023
Q1
Sell
-2,047
Closed -$835K 601
2022
Q4
$835K Buy
+2,047
New +$795K 0.13% 190
2022
Q3
Sell
-6,833
Closed -$2.4M 481
2022
Q2
$2.4M Buy
+6,833
New +$2.79M 0.48% 54
2022
Q1
Sell
-806
Closed -$531K 567
2021
Q4
$531K Buy
+806
New +$506K 0.21% 140
2020
Q4
Sell
-303
Closed -$119K 1019
2020
Q3
$119K Sell
303
-637
-68% -$236K 0.08% 265
2020
Q2
$310K Buy
+940
New +$272K 0.11% 242

Other funds holding IDXX

FORA Capital's IDXX Position: Q2 2026 in Review

FORA Capital increased its Idexx Laboratories (IDXX) stake by 142% in Q2 2026, buying an estimated $12.6M and bringing the position to 38,470 shares worth $20.2M. The position accounts for 1.39% of the portfolio, ranked #8.

FORA Capital first reported a position in IDXX in Q2 2020 and has held it in 12 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • FORA Capital held 38,470 shares of Idexx Laboratories worth $20.2M as of Q2 2026.
  • FORA Capital bought 22,545 Idexx Laboratories shares in Q2 2026, an estimated $12.6M.
  • Idexx Laboratories made up 1.39% of FORA Capital's portfolio in Q2 2026, its #8 holding.
  • FORA Capital first reported a position in Idexx Laboratories in Q2 2020 and has held it in 12 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.